We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Arcus Biosciences disclosed in a US Securities and Exchange Commission filing Monday that chief medical officer Bill Grossman will transition out of his role at the company to take up the post of senior vice president of oncology clinical research.